Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - VACCINEX, INC. | vcnx-ex321_731.htm |
| EX-31.2 - EX-31.2 - VACCINEX, INC. | vcnx-ex312_729.htm |
| EX-31.1 - EX-31.1 - VACCINEX, INC. | vcnx-ex311_730.htm |
| EX-10.28 - EX-10.28 - VACCINEX, INC. | vcnx-ex1028_806.htm |
| 10-K - 10-K - VACCINEX, INC. | vcnx-10k_20201231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-233607, 333-236416, 333-236417, 333-246322 and 333-246326 on Form S-3 and Registration Statement No. 333-226964 on Form S-8 of our report dated March 31, 2021, relating to the financial statements of Vaccinex, Inc. appearing in this Annual Report on Form 10-K of Vaccinex, Inc. for the year ended December 31, 2020.
/s/ Deloitte & Touche LLP
Rochester, New York
March 31, 2021